Cypher stent

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instance_of gptkb:medical_devices
gptkbp:approves gptkb:FDA
gptkbp:coat_of_arms gptkb:sirolimus
gptkbp:designed_for treatment of coronary artery disease
gptkbp:developed_by gptkb:Boston_Scientific
gptkbp:diameter 2.5 mm to 4.0 mm
gptkbp:first_introduced gptkb:2002
https://www.w3.org/2000/01/rdf-schema#label Cypher stent
gptkbp:is_associated_with improved patient outcomes
lower mortality rates
lower rates of target lesion revascularization
gptkbp:is_available_in various sizes
gptkbp:is_compared_to bare-metal stents
gptkbp:is_considered a standard treatment option
a significant advancement in cardiology
a breakthrough in stent technology
a safe option for many patients
gptkbp:is_evaluated_by clinical trials
safety and efficacy
long-term outcomes
gptkbp:is_implanted_during angioplasty procedure
gptkbp:is_linked_to improved quality of life for patients
reduced need for repeat procedures
gptkbp:is_part_of interventional cardiology procedures
cardiac catheterization procedures
cardiovascular treatment options
drug-eluting stent category
modern stenting techniques
stent technology
gptkbp:is_recommended_for patients with high risk of restenosis
gptkbp:is_regarded_as one of the first drug-eluting stents
gptkbp:is_subject_to regulatory approvals
gptkbp:is_tested_for randomized controlled trials
gptkbp:is_used_by interventional cardiologists
gptkbp:is_used_in emergency situations
various countries worldwide
gptkbp:is_used_to restore blood flow
open narrowed arteries
prevent heart attacks
gptkbp:length 8 mm to 38 mm
gptkbp:made_of stainless steel
gptkbp:manufacturer Boston Scientific Corporation
gptkbp:provides drug-eluting properties
gptkbp:reduces restenosis rates
gptkbp:success_rate high
gptkbp:suitable_for patients with allergy to sirolimus
gptkbp:used_in percutaneous coronary intervention
gptkbp:bfsParent gptkb:Cordis_Corporation
gptkbp:bfsLayer 5